BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang QL, Xie SH, Wahlin K, Lagergren J. Global time trends in the incidence of esophageal squamous cell carcinoma. Clin Epidemiol 2018;10:717-28. [PMID: 29950901 DOI: 10.2147/CLEP.S166078] [Cited by in Crossref: 37] [Cited by in F6Publishing: 18] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang C, Tong J, Tang M, Lu Y, Liang G, Zhang Z, Chen T. Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus. Cancer Manag Res 2021;13:1075-85. [PMID: 33574705 DOI: 10.2147/CMAR.S294344] [Reference Citation Analysis]
2 Yokoyama A, Omori T, Yokoyama T. Changing trends in cancer incidence of upper aerodigestive tract and stomach in Japanese alcohol-dependent men (1993-2018). Cancer Med 2020;9:837-46. [PMID: 31957322 DOI: 10.1002/cam4.2737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Luebeck GE, Vaughan TL, Curtius K, Hazelton WD. Modeling historic incidence trends implies early field cancerization in esophageal squamous cell carcinoma. PLoS Comput Biol 2021;17:e1008961. [PMID: 33939693 DOI: 10.1371/journal.pcbi.1008961] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Vošmik M, Hodek M, Buka D, Sýkorová P, Grepl J, Paluska P, Paulíková S, Sirák I. Cardiotoxicity of radiation therapy in esophageal cancer. Rep Pract Oncol Radiother 2020;25:318-22. [PMID: 32194352 DOI: 10.1016/j.rpor.2020.02.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 de Vegt F, Gommers JJJ, Groenewoud H, Siersema PD, Verbeek ALM, Peters Y, Broeders MJM. Trends and projections in the incidence of oesophageal cancer in the Netherlands: An age-period-cohort analysis from 1989 to 2041. Int J Cancer 2022;150:420-30. [PMID: 34605022 DOI: 10.1002/ijc.33836] [Reference Citation Analysis]
6 Sharma U, Barwal TS, Khandelwal A, Rana MK, Rana APS, Singh K, Jain A. Circulating Long Non-Coding RNAs LINC00324 and LOC100507053 as Potential Liquid Biopsy Markers for Esophageal Squamous Cell Carcinoma: A Pilot Study. Front Oncol 2022;12:823953. [DOI: 10.3389/fonc.2022.823953] [Reference Citation Analysis]
7 Xie SH, Santoni G, Lagergren J. Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study. Br J Cancer 2021. [PMID: 34671128 DOI: 10.1038/s41416-021-01575-8] [Reference Citation Analysis]
8 Li H, Li H, Waresijiang Y, Chen Y, Li Y, Yu L, Li Y, Liu L. Clinical significance of HDAC1, -2 and -3 expression levels in esophageal squamous cell carcinoma. Exp Ther Med 2020;20:315-24. [PMID: 32536999 DOI: 10.3892/etm.2020.8697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Then EO, Lopez M, Saleem S, Gayam V, Sunkara T, Culliford A, Gaduputi V. Esophageal Cancer: An Updated Surveillance Epidemiology and End Results Database Analysis. World J Oncol 2020;11:55-64. [PMID: 32284773 DOI: 10.14740/wjon1254] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 17.5] [Reference Citation Analysis]
10 Choksi D, Kolhe KM, Ingle M, Rathi C, Khairnar H, Chauhan SG, Chaudhary V, Shukla A, Pandey V. Esophageal carcinoma: An epidemiological analysis and study of the time trends over the last 20 years from a single center in India. J Family Med Prim Care 2020;9:1695-9. [PMID: 32509674 DOI: 10.4103/jfmpc.jfmpc_1111_19] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Cheng J, Ma H, Yan M, Xing W. THAP9-AS1/miR-133b/SOX4 positive feedback loop facilitates the progression of esophageal squamous cell carcinoma. Cell Death Dis 2021;12:401. [PMID: 33854048 DOI: 10.1038/s41419-021-03690-z] [Reference Citation Analysis]
12 Thrift AP. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Rev Gastroenterol Hepatol 2021;18:432-43. [PMID: 33603224 DOI: 10.1038/s41575-021-00419-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
13 Gillman A, Hayes M, Sheaf G, Walshe M, Reynolds JV, Regan J. Exercise-based dysphagia rehabilitation for adults with oesophageal cancer: a systematic review. BMC Cancer 2022;22:53. [PMID: 35012495 DOI: 10.1186/s12885-021-09155-y] [Reference Citation Analysis]
14 Shen L, Kato K, Kim SB, Ajani JA, Zhao K, He Z, Yu X, Shu Y, Luo Q, Wang J, Chen Z, Niu Z, Zhang L, Yi T, Sun JM, Chen J, Yu G, Lin CY, Hara H, Bi Q, Satoh T, Pazo-Cid R, Arkenau HT, Borg C, Lordick F, Li L, Ding N, Tao A, Shi J, Van Cutsem E; RATIONALE-302 Investigators. Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study. J Clin Oncol 2022;:JCO2101926. [PMID: 35442766 DOI: 10.1200/JCO.21.01926] [Reference Citation Analysis]
15 Liu R, Zhang X, Zhang Q, Luo H, Wei S, Liu T, Sun S, Liu Z, Li Z, Tian J, Wang X. Adjuvant Radiotherapy of Involved Field versus Elective Lymph Node in Patients with Operable Esophageal Squamous Cell Cancer: A Single Institution Prospective Randomized Controlled Study. J Cancer 2021;12:3180-9. [PMID: 33976727 DOI: 10.7150/jca.50108] [Reference Citation Analysis]
16 Zhou P, Li Z, Xu D, Wang Y, Bai Q, Feng Y, Su G, Chen P, Wang Y, Liu H, Wang X, Zhang R, Wang Y. Cepharanthine Hydrochloride Improves Cisplatin Chemotherapy and Enhances Immunity by Regulating Intestinal Microbes in Mice. Front Cell Infect Microbiol 2019;9:225. [PMID: 31293986 DOI: 10.3389/fcimb.2019.00225] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
17 Huang J, Zhao L, Gong C, Wang Y, Qu Y, Ji C, Yang J. Shikonin Promotes Apoptosis and Attenuates Migration and Invasion of Human Esophageal Cancer Cells by Inhibiting Tumor Necrosis Factor Receptor-Associated Protein 1 Expression and AKT/mTOR Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:5386050. [PMID: 34812264 DOI: 10.1155/2021/5386050] [Reference Citation Analysis]
18 Wang SM, Katki HA, Graubard BI, Kahle LL, Chaturvedi A, Matthews CE, Freedman ND, Abnet CC. Population Attributable Risks of Subtypes of Esophageal and Gastric Cancers in the United States. Am J Gastroenterol 2021;116:1844-52. [PMID: 34240714 DOI: 10.14309/ajg.0000000000001355] [Reference Citation Analysis]
19 Huang J, Koulaouzidis A, Marlicz W, Lok V, Chu C, Ngai CH, Zhang L, Chen P, Wang S, Yuan J, Lao XQ, Tse SLA, Xu W, Zheng ZJ, Xie SH, Wong MCS. Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries. Cancers (Basel) 2021;13:E141. [PMID: 33466239 DOI: 10.3390/cancers13010141] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
20 Miller HK, Stoddard RA, Dawsey SM, Nasrollahzadeh D, Abnet CC, Etemadi A, Kamangar F, Murphy G, Sotoudeh M, Kersh GJ, Malekzadeh R, Camargo MC. Association Between Serological Responses to Two Zoonotic Ruminant Pathogens and Esophageal Squamous Cell Carcinoma. Vector Borne Zoonotic Dis 2021;21:125-7. [PMID: 33121389 DOI: 10.1089/vbz.2020.2668] [Reference Citation Analysis]
21 Cameniţă D, Demetrian AD, Pleşea RM, Tănasie-Vasile MI, Strâmbu VDE, Grigorean VT, Ioniţă E, Pleşea IE, Marincaş AM. Clinical-morphological profiles of esophageal carcinoma's main types. Rom J Morphol Embryol 2020;61:407-22. [PMID: 33544792 DOI: 10.47162/RJME.61.2.10] [Reference Citation Analysis]
22 Khairan P, Sobue T, Eshak ES, Zha L, Kitamura T, Sawada N, Iwasaki M, Inoue M, Yamaji T, Shimazu T, Iso H, Tsugane S. Association of dietary intakes of vitamin B12, vitamin B6, folate, and methionine with the risk of esophageal cancer: the Japan Public Health Center-based (JPHC) prospective study. BMC Cancer 2021;21:982. [PMID: 34470601 DOI: 10.1186/s12885-021-08721-8] [Reference Citation Analysis]
23 Yokoyama A, Omori T, Yokoyama T. Risk factors for esophageal iodine-unstained lesions and changing trends among Japanese alcohol-dependent men (2003-2018). Cancer Sci 2021;112:734-43. [PMID: 33249700 DOI: 10.1111/cas.14753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 Saito E, Yano T, Hori M, Yoneoka D, Matsuda T, Chen Y, Katanoda K. Is young‐onset esophageal adenocarcinoma increasing in Japan? An analysis of population‐based cancer registries. Cancer Medicine. [DOI: 10.1002/cam4.4528] [Reference Citation Analysis]
25 Tan MC, Bhushan S, Quang T, Schwarz R, Patel KH, Yu X, Li Z, Wang G, Zhang F, Wang X, Xu H, Richards-Kortum RR, Anandasabapathy S. Automated software-assisted diagnosis of esophageal squamous cell neoplasia using high-resolution microendoscopy. Gastrointest Endosc 2021;93:831-838.e2. [PMID: 32682812 DOI: 10.1016/j.gie.2020.07.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Wu IC, Wang YK, Chen YH, Wu CC, Wu MC, Chen WC, Wang WL, Lin HS, Chen CC, Chou SH, Liu YP, Wu MT. High Serum Elafin Prediction of Poor Prognosis of Locoregional Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2021;13:3082. [PMID: 34205756 DOI: 10.3390/cancers13123082] [Reference Citation Analysis]